ABSI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Absci Corp (ABSI) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock exhibits a bullish technical trend, strong analyst support with upward price target revisions, and significant growth potential driven by its lead asset ABS-201. While hedge funds are selling, the overall sentiment remains positive, and the options data indicates strong bullish sentiment.
The stock shows a bullish trend with MACD histogram above 0 and positively expanding, RSI at 67.247 in the neutral zone, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot level of 7.024, with resistance levels at 7.827 and 8.322, indicating further upside potential.
Analysts have raised price targets significantly, with Guggenheim increasing its target to $15 and highlighting ABS-201's multi-billion-dollar sales potential.
The company's AI platform is seen as a technological moat.
Upcoming catalysts include Phase 2 data for ABS-201 in androgenetic alopecia and endometriosis, which could significantly de-risk the program and boost valuation.
Hedge funds are selling, with a 1029.38% increase in selling activity over the last quarter.
Morgan Stanley maintains an Equal Weight rating with a lower price target of $4.10, indicating some skepticism about near-term performance.
No financial data is available for analysis due to an error in the provided data.
Analysts are overwhelmingly positive on the stock, with multiple Buy ratings and upward price target revisions. Guggenheim, Leerink, and BTIG highlight the transformative potential of ABS-201 and the company's AI platform. However, Morgan Stanley remains cautious with an Equal Weight rating and a lower price target.
